This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
News
7 Dec 2022 Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics
Read more
4 Sep 2022 Ibex announces Galen™ 3.0, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set
Read more
2 Sep 2022 Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France
Read more
15 Jun 2022 Ibex obtains CE mark for Galen Gastric, the world’s first AI-powered solution for gastric cancer detection
Read more
21 Mar 2022 Hartford HealthCare and Ibex launch research initiative on AI-powered solution to improve breast cancer diagnosis
Read more
10 Mar 2022 Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology
Read more
24 Nov 2021 Ibex selected by India’s Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics
Read more
3 Nov 2021 Ibex selected by Kantonsspital Baselland to deliver the first AI-powered cancer diagnostics solution in Switzerland
Read more
18 Oct 2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care
Read more